Source: Annual Congress 2003 - Clinical pathobiology in airway disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. H. Lopez, M. E. B. Limpin, P. A. Punzal, T. S. de Guia (The Philippines). Serum uric acid levels among COPD patients. Eur Respir J 2003; 22: Suppl. 45, 2781

Member's Comments

No comment yet.

Related content which might interest you: Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Assessment of serum uric acid in COPD exacerbations Source: International Congress 2017 – Markers of COPD progression Year: 2017 Blood plasma levels of ascorbic acid in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Serum uric acid as a predictor of mortality and future exacerbations of COPD Source: Eur Respir J 2014; 43: 43-53 Year: 2004 Serum levels of hyaluronic acid are associated with COPD severity and predict survival Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018 Year: 2019 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Total serum bilirubin levels are not related to the severity of COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Elevation of plasma cystatin C levels in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Plasma amino acid profiles in patients of various respiratory disorders Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Serum KL-6 level and DTPA clearance in systemic sclerosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019